Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Pain medications are defined as opioids, non-steroidal anti-inflammatory drugs (NSAIDS), and acetaminophen.
Each new drug application that goes through the FDA Approval Process is given a unique identifier and, once approved by the FDA, is required to list the product with the FDA in the database. The data for this objective will select Drug Listings for a given year that are determined to be “Unapproved” in the Drug Registration and Listing Database. The goal of this objective is to decrease the overall number of “Unapproved” drugs that are marketed and, subsequently listed with the FDA. This is not to imply that “Unapproved” drugs should not be listed with the FDA, but that the number of “Unapproved” marketed drugs should be minimized.
The estimates are reflective of the drugs that have multiple ingredients, potency levels in a drug, and different routes of administration.
Additional resources about the objective.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link